Deep Bio
Latest round
- Series B
Last raised
- Jun 2020
Total raised
- $13M
Investors
- 10
About Deep Bio
Based in South Korea, Deep Bio Inc.Deep Bio Inc. is a healthcare technology firm established in 2015 in Seoul, South Korea, aimed at enhancing cancer diagnostics. The founder, Sun-woo Kim, also serves as the CEO.Deep Bio specializes in artificial intelligence-driven solutions for cancer diagnostics, primarily offering its flagship product, the DeepDx® suite. This suite includes applications such as DeepDx® Prostate, designed for the detection and diagnosis of prostate cancer through advanced image analysis techniques. Leveraging deep learning algorithms, DeepDx® enhances the accuracy of pathology assessments, assisting medical professionals in making informed treatment decisions.7 million.3 billion, the company plans to enhance its product offerings and expand into new geographic markets. Investments will focus on developing additional AI-driven diagnostic tools, aiming for release by the end of 2024. Deep Bio is targeting further expansion in North America and Europe, leveraging the recent capital to support these initiatives and strengthen its market presence.
Who invested in Deep Bio
10 investors across 3 rounds
See all investors in Deep Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Deep Bio
Who invested in Deep Bio?
Deep Bio has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Deep Bio raised?
Deep Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Deep Bio last raise money?
Deep Bio's most recent round on record is a Series B, in Jun 2020.
What does Deep Bio do?
Based in South Korea, Deep Bio Inc.
Where is Deep Bio headquartered?
Deep Bio is headquartered in Seoul, South Korea.
Which VCs invest in companies like Deep Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back healthcare it companies at Deep Bio's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like Deep Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.